Coverart for item
The Resource Conflict of interest, protection of public ownership, in drug development deals between tax-exempt, federally supported labs and the pharmaceutical industry : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, first session

Conflict of interest, protection of public ownership, in drug development deals between tax-exempt, federally supported labs and the pharmaceutical industry : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, first session

Label
Conflict of interest, protection of public ownership, in drug development deals between tax-exempt, federally supported labs and the pharmaceutical industry : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, first session
Title
Conflict of interest, protection of public ownership, in drug development deals between tax-exempt, federally supported labs and the pharmaceutical industry
Title remainder
hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, first session
Creator
Subject
Genre
Language
eng
Related
Cataloging source
GPO
Government publication
federal national government publication
Index
no index present
Literary form
non fiction
http://bibfra.me/vocab/lite/organizationName
United States
http://library.link/vocab/subjectName
  • Drugs
  • Drugs
  • Research and development contracts, Government
  • Pharmaceutical industry
  • Conflict of interests
  • Norgestrel
  • Contraceptives
  • Research and development partnership
Label
Conflict of interest, protection of public ownership, in drug development deals between tax-exempt, federally supported labs and the pharmaceutical industry : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, first session
Instantiates
Publication
Note
  • CIS Microfiche Accession Numbers: CIS 93 H721-22 (pt.1), CIS 93 H721-34 (pt.2), CIS 94 H721-20 (pt.3)
  • "Serial no. 103-5"--Pt. 1
  • "Serial no. 103-25"--Pt. 2
  • "Serial no. 103-59"--Pt. 3
  • "Washington, DC, March 11, 1993"--Pt. 1
  • "Washington, DC, June 17, 1993"--Pt. 2
  • "Washington, DC, November 10, 1993"--Pt. 3
  • Title on Part 3 is: Norplant and contraceptive pricing
  • Reuse of record except for individual research requires license from Congressional Information Service, Inc
Base of film
safety base undetermined
Carrier category
microfiche
Carrier category code
he
Carrier MARC source
rdacarrier
Color
black and white
Content category
text
Content type code
txt
Content type MARC source
rdacontent
Dimensions
24 cm
Dimensions
4x6 in. or 11x15 cm.
Emulsion on film
silver halide
Extent
volumes
Form of item
microfiche
Generation
service copy
Media category
microform
Media MARC source
rdamedia
Media type code
h
Other physical details
illustrations
Positive negative aspect
negative
http://bibfra.me/vocab/marc/reductionRatio
02
ReductionRatioRange
normal reduction
Reproduction note
Microfiche.
Specific material designation
microfiche
System control number
  • gp 93087758
  • (OCoLC)28658789
Label
Conflict of interest, protection of public ownership, in drug development deals between tax-exempt, federally supported labs and the pharmaceutical industry : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, first session
Publication
Note
  • CIS Microfiche Accession Numbers: CIS 93 H721-22 (pt.1), CIS 93 H721-34 (pt.2), CIS 94 H721-20 (pt.3)
  • "Serial no. 103-5"--Pt. 1
  • "Serial no. 103-25"--Pt. 2
  • "Serial no. 103-59"--Pt. 3
  • "Washington, DC, March 11, 1993"--Pt. 1
  • "Washington, DC, June 17, 1993"--Pt. 2
  • "Washington, DC, November 10, 1993"--Pt. 3
  • Title on Part 3 is: Norplant and contraceptive pricing
  • Reuse of record except for individual research requires license from Congressional Information Service, Inc
Base of film
safety base undetermined
Carrier category
microfiche
Carrier category code
he
Carrier MARC source
rdacarrier
Color
black and white
Content category
text
Content type code
txt
Content type MARC source
rdacontent
Dimensions
24 cm
Dimensions
4x6 in. or 11x15 cm.
Emulsion on film
silver halide
Extent
volumes
Form of item
microfiche
Generation
service copy
Media category
microform
Media MARC source
rdamedia
Media type code
h
Other physical details
illustrations
Positive negative aspect
negative
http://bibfra.me/vocab/marc/reductionRatio
02
ReductionRatioRange
normal reduction
Reproduction note
Microfiche.
Specific material designation
microfiche
System control number
  • gp 93087758
  • (OCoLC)28658789

Library Locations

    • Biddle Law LibraryBorrow it
      3400 Chestnut Street, Philadelphia, Pennsylvania, 19104, US
      39.954941 -75.193362
Processing Feedback ...